Key result
The new CKD-EPI equation independently predicted the composite of major bleeding, thromboembolism, and mortality (HR 0.97, P<0.0001), performing similarly to the re-expressed MDRD equation.
Why the study?
Does the CKD-EPI equation perform differently than the re-expressed MDRD equation in predicting major adverse outcomes in patients with non-valvular atrial fibrillation?
Cohort (n=911)
Does the CKD-EPI equation perform differently than the re-expressed MDRD equation in predicting major adverse outcomes in patients with non-valvular atrial fibrillation?
Hazard Ratio: 0.97
p-value: p=< 0.0001
The CKD-EPI equation reduces the estimated prevalence of renal dysfunction compared to the MDRD equation, but both perform similarly in predicting major adverse outcomes in patients with non-valvular atrial fibrillation on vitamin-K antagonists.
AIM: To compare the performance of the re-expressed Modification of Diet in Renal Disease equation vs the new Chronic Kidney Disease Epidemiology Collaboration equation in patients with non-valvular atrial fibrillation. METHODS: We studied 911 consecutive patients with non-valvular atrial fibrillation on vitamin-K antagonist. The performance of the re-expressed Modification of Diet in Renal Disease equation vs the new Chronic Kidney Disease Epidemiology Collaboration equation in patients with non-valvular atrial fibrillation with respect to either a composite endpoint of major bleeding, thromboembolic events and all-cause mortality or each individual component of the composite endpoint was assessed using continuous and categorical ≥ 60, 59-30, and < 30 mL/min per 1.73 m(2) estimated glomerular filtration rate. RESULTS: During 10 ± 3 mo, the composite endpoint occurred in 98 (10.8%) patients: 30 patients developed major bleeding, 18 had thromboembolic events, and 60 died. The new equation provided lower prevalence of renal dysfunction < 60 mL/min per 1.73 m(2) (32.9%), compared with the re-expressed equation (34.1%). Estimated glomerular filtration rate from both equations was independent predictor of composite endpoint (HR = 0.98 and 0.97 for the re-expressed and the new equation, respectively; P < 0.0001) and all-cause mortality (HR = 0.98 for both equations, P < 0.01). Strong association with thromboembolic events was observed only when estimated glomerular filtration rate was < 30 mL/min per 1.73 m(2): HR is 5.1 for the re-expressed equation, and HR = 5.0 for the new equation. No significant association with major bleeding was observed for both equations. CONCLUSION: The new equation reduced the prevalence of renal dysfunction. Both equations performed similarly in predicting major adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Rami Riziq-Yousef Abumuaileq (2015) conducted a cohort in non-valvular atrial fibrillation (n=911). Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation vs. re-expressed Modification of Diet in Renal Disease (MDRD) equation was evaluated on composite endpoint of major bleeding, thromboembolic events and all-cause mortality (HR 0.97, p=< 0.0001). The new CKD-EPI equation independently predicted the composite of major bleeding, thromboembolism, and mortality (HR 0.97, P<0.0001), performing similarly to the re-expressed MDRD equation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: